FB23 ‐2 and Cisplatin Synergize to Inhibit Head and Neck Squamous Cell Carcinoma by Targeting the XPF / ERCC1 Complex

Ähnliche Einträge

• Correction to ‘ MUC1 as a Target for CAR ‐T Therapy in Head and Neck Squamous Cell Carcinoma’
  Veröffentlicht: (2024)
• Ligand‐Receptor Interactions Between Squamous and Endothelial Cells Induce Head and Neck Squamous Cell Carcinoma
  von: Takahiro Ishiyama, et al.
  Veröffentlicht: (2025)
• USP5 Promotes Head and Neck Squamous Cell Carcinoma Progression via mTOR Signaling Pathway
  von: Ni Xiong, et al.
  Veröffentlicht: (2025)
• Molecular and Cell Biological Characterization of Patient‐Derived Head and Neck Squamous Carcinoma Cell Lines
  von: Kazue Ito, et al.
  Veröffentlicht: (2026)
• Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma
  von: Changyu Zhu, et al.
  Veröffentlicht: (2025)